Bringing the fundamentals into focus…
Back to HUTCHMED (China) Limited
How HUTCHMED (China) Limited stacks up
HCM · against 386 other Healthcare companies of similar size
Valuation
75/ 100
Above the middle of the pack.
Ranked #107 of 387 · scores higher than 72% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 70–79, including HCM · Click a bar to see the companies
Why valuation scores 75?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -2.6% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 20.1% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -3.5% vs peer median 0.0%
Metric by metric
Position: dot = HCM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | HCM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 376 reported | 0.8% | 1.8% | 41% | 30% | |
| EBITDA yieldHigher is better · 385 reported | -2.2% | 4.3% | 23% | 50% | |
| Free cash flow yieldHigher is better · 194 reported | Not reported | -0.5% | — | — | 20% |
| Book yieldHigher is better · 377 reported | 55.5% | 33.5% | 74% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around HCMScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score